Immuneering
IMRX
IMRX
39 hedge funds and large institutions have $12.9M invested in Immuneering in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.89% less ownership
Funds ownership: 12.53% → 10.64% (-1.9%)
Holders
39
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$379K | |
| 2 | +$182K | |
| 3 | +$109K | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$89.1K |
| 5 |
Millennium Management
New York
|
+$67.2K |
Top Sellers
| 1 | -$1M | |
| 2 | -$456K | |
| 3 | -$401K | |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$126K |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$108K |